Yuan Long Luo
Directeur/Membre du Conseil chez BEIJING CHIEFTAIN CONTROL ENGINEERING TECHNOLOGY CO., LTD.
Provenance du réseau au premier degré de Yuan Long Luo
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Industrial Machinery | 22 | |
Guangzhou Longest Science & Technology Co. Ltd.
 Guangzhou Longest Science & Technology Co. Ltd. Medical SpecialtiesHealth Technology Guangzhou Longest Science & Technology Co., Ltd. engages in research, development, manufacture and sale of physiotherapy and medical aesthetics devices. Its products include radial extracorporeal shockwave therapy, interference and vacuum therapy, magnet therapy, pressotherapy, intense pulsed light and other types of medical aesthetics devices. The company was founded on January 26, 2000 by Luo Yuan Long and is headquartered in Guangzhou, China.
5
| Private Company | Medical Specialties | 5 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Yuan Long Luo via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| Tianjin University | College/University | Undergraduate Degree | |
| ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| JOINTO ENERGY INVESTMENT CO., LTD. HEBEI | Electric Utilities | Director/Board Member | |
| HUMANWELL HEALTHCARE (GROUP) CO.,LTD. | Pharmaceuticals: Major | Director/Board Member | |
Orient Fund Management Co., Ltd.
 Orient Fund Management Co., Ltd. Investment ManagersFinance Orient Fund Management Co., Ltd. (Orient FM) is the fund management subsidiary of Northeast Securities Co., Ltd. (SHE: 000686) in China. Founded in 2004, Orient FM is headquartered in Beijing and manages open-end mutual funds for private individuals. | Investment Managers | Portfolio Manager-Equities | |
| Nankai University | College/University | Masters Business Admin | |
| SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
| Chinese Pharmaceutical Enterprises Association | Corporate Officer/Principal | ||
| CISEN PHARMACEUTICAL CO., LTD. | Medical Specialties | Director/Board Member | |
| Xuanwu Hospital Capital Medical University | College/University | Corporate Officer/Principal | |
| Chinese Pharmacological Society | Corporate Officer/Principal | ||
| Beijing Eastern Chieftain Technology Co., Ltd. | Director/Board Member Chief Executive Officer | ||
Beijing Zhiyi Cultural Art Co., Ltd.
 Beijing Zhiyi Cultural Art Co., Ltd. Catalog/Specialty DistributionRetail Trade Beijing Zhiyi Cultural Art Co., Ltd. operates an online auction platform. It sells artworks and antique collections, oil and watercolor paintings, and Chinese paintings and calligraphies. The company was founded by Hao Zhang on August 1, 2014 and is headquartered in Beijing, China. | Catalog/Specialty Distribution | Director/Board Member | |
| DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD. | Miscellaneous Commercial Services | Director/Board Member | |
Hangzhou Shangjian Biotechnology Co., Ltd.
 Hangzhou Shangjian Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology Hangzhou Shangjian Biotechnology Co., Ltd. is a company that develops, manufactures, and markets therapeutic antibody drugs and antibodies. The company is based in Hangzhou, China. The Chinese company was founded in 2015 by Ming Lu, who has been the CEO since 2015. | Pharmaceuticals: Major | Director/Board Member | |
Shanghai Haihe Biopharma Co., Ltd.
 Shanghai Haihe Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Haihe Biopharma Co., Ltd engages in the development, production, and sale of anti-tumor innovative drugs. It focuses on new anti-tumor drug projects, providing cancer therapies, and development of anti-tumor drugs such as oral paclitaxel, tyrosine kinase inhibitors, PI3Ka inhibitors, and Glumetinib. The company was founded on March 11, 2011 and is headquartered in Shanghai, China. | Miscellaneous Commercial Services | Director/Board Member | |
Dizal Pharma
 Dizal Pharma BiotechnologyHealth Technology Dizal Pharma is a Chinese biotechnology company that operates in an undisclosed location. The company was founded in 2017, and its CEO is Xiao Lin Zhang. | Biotechnology | Director/Board Member | |
Beijing Liweite Investment Co., Ltd.
 Beijing Liweite Investment Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Beijing Liweite Investment Co., Ltd. provides business services. Beijing Liweite Investment Co., Ltd. is based in Beijing, China. The Chinese company was founded in 2009. The CEO is Xue Xian Liang. | Miscellaneous Commercial Services | Director/Board Member |
Statistiques
Internationale
| Chine | 19 |
Sectorielle
| Health Technology | 7 |
| Consumer Services | 4 |
| Commercial Services | 4 |
| Utilities | 2 |
| Finance | 2 |
Opérationnelle
| Director/Board Member | 38 |
| Independent Dir/Board Member | 13 |
| Corporate Officer/Principal | 8 |
| Chief Executive Officer | 4 |
| Investor Relations Contact | 3 |
Relations les plus connectées
| Insiders | |
|---|---|
| Xue Gong Wang | 9 |
| Fu Qing Wang | 4 |
| Qiang Zhao | 3 |
| Di Liu | 3 |
| Wen Wang | 3 |
| Qing Ji You | 2 |
| Kai Liang | 2 |
| Yi Peng Qiu | 2 |
| Jian Wang | 1 |
| Zhen Hua Lu | 1 |
| Jin Ting Zhang | 1 |
| Yun Xu | 1 |
| Yan Li Fan | 1 |
| Yi Liang | 1 |
| Xu Jun Li | 1 |
- Bourse
- Insiders
- Yuan Long Luo
- Connexions Sociétés
